BioTelemetry Will Provide Cardiac Monitoring for Apple’s Heart Study


November 30, 2017—BioTelemetry, Inc. announced a partnership with Apple to provide cardiac monitoring services in conjunction with the Apple Heart Study, which is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated Apple Heart Study app. The study was launched on November 30.

According to the company, the first indication of a cardiac arrhythmia is too often the occurrence of a life-threatening event. The Apple initiative will potentially benefit patients who are unaware that they may be at risk for serious health issues. BioTelemetry is a mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.